MedTrace Logo

Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial

NCT00937092 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2010-05-26

No results posted yet for this study

Summary

The aim of this study is to compare the effects of high-dose furosemide versus low-dose furosemide combined with low-dose dopamine on diuresis, renal function, electrolyte balance, and 60-day post-discharge outcomes in patients hospitalized with acute decompensated heart failure.

Conditions

  • Acute Heart Failure

Interventions

DRUG

Furosemide

High-dose furosemide(HDF, furosemide 20 mg/h intravenously)

DRUG

low-dose dopamine + low-dose furosemide

low-dose furosemide combined with low-dose dopamine (LDFD, furosemide 5 mg/h plus dopamine 5μg/kg/min intravenously)

Sponsors & Collaborators

  • Larissa University Hospital

    lead OTHER

Principal Investigators

  • Gregory Giamouzis, MD · Larissa University Hospital

  • Filippos Triposkiadis, MD · Larissa University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-01-31
Completion
2012-07-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00937092 on ClinicalTrials.gov